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Abstract
A biomathematical model was previously developed to describe the long-term clearance and 
retention of particles in the lungs of coal miners. The model structure was evaluated and 
parameters were estimated in two data sets, one from the United States and one from the United 
Kingdom. The three-compartment model structure consists of deposition of inhaled particles in the 
alveolar region, competing processes of either clearance from the alveolar region or translocation 
to the lung interstitial region, and very slow, irreversible sequestration of interstitialized material 
in the lung-associated lymph nodes. Point estimates of model parameter values were estimated 
separately for the two data sets. In the current effort, Bayesian population analysis using Markov 
chain Monte Carlo simulation was used to recalibrate the model while improving assessments of 
parameter variability and uncertainty. When model parameters were calibrated simultaneously to 
the two data sets, agreement between the derived parameters for the two groups was very good, 
and the central tendency values were similar to those derived from the deterministic approach. 
These findings are relevant to the proposed update of the ICRP human respiratory tract model with 
revisions to the alveolar-interstitial region based on this long-term particle clearance and retention 
model.
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A biomathematical model was previously developed to describe the long-term clearance and 
retention of particles in the lungs of coal miners, which included separate evaluations of 
model structure and model parameter calibration1 in two data sets, one from the United 
States (US) and one from the United Kingdom (UK) (Kuempel et al., 2001a,b; Tran and 
Buchanan, 2000). The model structure consists of deposition of inhaled particles in the 
pulmonary (alveolar) region, clearance from the alveolar region to the tracheo-bronchial 
region or translocation to the lung interstitium, and irreversible sequestration of 
interstitialized material. Each of these processes was described as first order. The structure 
of this three-compartment sequestration model describes additional processes that were not 
captured in a simple one-compartment model (Kuempel, 2000). Previous analyses also 
showed that the process of dose-dependent overloading of lung clearance as observed in rats 
did not adequately fit the coal miner data (Kuempel, 2000; Kuempel et al., 2001a; Tran and 
Buchanan, 2000). This three-compartment sequestration model has been shown to best 
predict the long-term retention behavior observed in US and UK coal miners and (more 
recently) in workers with relatively low exposure to radioactive cobalt or plutonium 
(Gregoratto et al., 2010, 2011). In contrast, other first-order human lung clearance models 
(NCRP, 1997; ICRP, 1994) were shown to underpredict the human retained lung particle 
burden data (Kuempel and Tran, 2002). In addition, a rat-based model (extrapolated to 
humans) with normal first-order clearance followed by dose-dependent impairment of 
clearance (overloading) (Hsieh and Yu, 1998) both underestimated the human retained lung 
dose at low exposures and overestimated the lung dose at higher exposures (Kuempel and 
Tran, 2002).
The model structure in Kuempel et al. (2001a) was recently adopted by the International 
Commission on Radiological Protection (ICRP) to describe the long-term clearance and 
retention of inhaled particles in the alveolar-interstitial region of the human respiratory tract 
model (HRTM) (Bailey et al., 2007, 2008) [draft revision of the ICRP (1994) model and 
comments on the draft available at: http://www.icrp.org/page.asp?id = 155)]. This model 
structure is considered to be physiologically more realistic and provides a simpler model that 
adequately represents the long-term retained lung dose in humans in several studies 
(described in Gregoratto et al., 2010). The initial model development and parameter 
estimates were based on a US coal miner autopsy study (Kuempel, 2000), and the model 
structure was independently evaluated and validated using UK coal miner data (Tran and 
Buchanan, 2000). The model calibration was also performed separately, and different point 
estimates of the optimal parameters were obtained for each of these data sets.
To facilitate implementation in the HRTM update, it is of interest to examine whether these 
differences in the US and UK parameter estimates are systematic, or whether these best-fit 
point estimates are consistent with a single distribution of values for each parameter in the 
larger population. The optimal point estimates of the model parameters were originally 
1The term “calibration” in biokinetic modeling generally means the estimation and optimization of the model parameter values. When 
multiple data sets are available, some of the data may be used for model “calibration,” and the others for validation of the original 
values (e.g., Chiu et al., 2009).
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estimated separately in each data set by identifying those parameter values that minimizing 
the mean squared error (MSE) in fitting the model to the data (Kuempel, 2000; Kuempel et 
al., 2001a; Tran and Buchanan, 2000). In addition to point estimates, the current analysis 
provides estimates of the distributions of parameter values, which are needed to characterize 
the variability in predicted lung burdens in the human population.
For the current analysis, Bayesian population analysis using Markov chain Monte Carlo 
(MCMC) simulation is considered an appropriate method for calibrating this particle 
clearance and retention model. This approach permits parameters to be simultaneously 
calibrated for multiple data sets using uninformative prior parameter distributions that 
minimize bias (Bernillon and Bois, 2000; Lunn et al., 2009; Jonsson and Johanson, 2003; 
Hack, 2006; Hack et al., 2006). Distributions were estimated for the parameters in this three-
compartment model, rather than point estimates, to provide information on variability in the 
lung dose estimates in the population. This analysis also helps to reduce uncertainty in 
human lung dose estimation by better characterizing the distribution in the parameters 
influencing the long-term clearance and retention of inhaled particles in the lungs.
2. Materials and methods
2.1. Key data sets and model structure
The US data are from a study by the late Werner Laqueur, M.D., who systematically 
collected approximately 600 cases from consecutive autopsies at Beckley Appalachian 
Regional Hospital in West Virginia. Lung dust burden was measured for 141 of these coal 
miners, who were autopsied between 1962 and 1968. Of the 141 miners, 128 miners had the 
minimal information specified in the original model parameter calibration, which included 
(in addition to the lung dust burden), the duration of employment in mining, the mining job 
history (to assign job-specific exposure concentration), and the dates and/or ages at 
retirement and death (to compute the post-exposure duration) (Kuempel et al., 2001a). Of 
these, 57 miners also had data on the lung-associated lymph node dust burden. The work 
histories were derived from questionnaires provided to the next-of-kin, clinical records, and 
mine company records (Kuempel et al., 2001a). In the current analysis, an additional 8 
individuals were omitted due to discrepancies in tabulated values for ages, work experience, 
and death, which resulted in 120 US coal miners with lung burden, and 54 with lymph node 
data, for this MCMC-based parameter estimation.
The miners in the UK study were participants in the British National Coal Board's 
Pneumoconiosis Field Research program, which was set up in the 1950s, with lung autopsy 
dust burden data becoming available in the 1970s (Tran and Buchanan, 2000). Usable data 
(i.e., information on exposure, lung burden, age) was available for 514 individuals in the 
British study. For 115 of these individuals, lymph node dust burden data were also available 
(Tran and Buchanan, 2000).
Briefly, the model structure (illustrated in Fig. 1) consisted of the deposition of inhaled dust 
in the alveolar (gas-exchange) region; the competing processes of either particle clearance 
from the alveolar region (rate: KT) or particle translocation to the interstitial region (rate: 
KI); and the very slow (irreversible) translocation of interstitialized material in the hilar 
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(lung-associated) lymph nodes (rate: KLN) The original parameter estimation for this model 
was performed using a systematic grid search within biologically plausible ranges of KT, 
KI, and KLN (identified from human and animal studies in the literature; Table 4 of 
Kuempel et al., 2001a). In addition, a fixed value of the average alveolar deposition fraction 
(ICRP, 1994) was estimated on the reported airborne coal mine particle size data (Jones et 
al., 1988a; Burkhart et al., 1987). The clearance parameters were then iteratively varied to 
determine the best fit of the model to the data (Kuempel et al., 2001a). The optimal 
parameter values were estimated as those that minimized the MSE in fitting the model to the 
data. Evaluation of the evidence for possible dose-dependent KT was a focus of the original 
model development (Kuempel, 2000; Kuempel et al., 2001a). In the best-fitting model, each 
of these processes is described as first-order because the inclusion of biomathematical 
equations describing varying degrees of dose-dependent impairment of alveolar clearance 
(KT) did not improve the model fit to either the US or the UK data (Kuempel, 2000; Tran 
and Buchanan, 2000). The equations describing the model and parameters (both original and 
updated) are provided in Appendix A.
2.2. Model implementation/model calibration
The previously used model code (Kuempel et al., 2001a,b) was adapted to the conventions 
for MCSim (version 5.3.1). Extensive reformatting was conducted on the input files. The 
UK files in particular required extensive preprocessing because of greater detail in the 
exposure histories (i.e., several changes in exposure concentration throughout individuals' 
employment). The reported concentrations were converted to adjusted concentrations based 
on a standardized work schedule (per the format of the US data, with respect to numbers of 
hours per day and per year; i.e., from estimated average of 1740 h/yr in UK data to 2000h/yr 
in US data, assuming 8 h/d, 5 d/wk, 50 wk/yr).
To facilitate the MCMC analysis, a statistical model was generated in order to implement a 
Bayesian approach. Bayesian modeling draws from two types of knowledge to derive model 
parameter estimates: prior knowledge, as described in initial parameter distributions, and 
information that can be deduced from measured data, if appropriately analyzed (Gelman et 
al., 1996; Bernillon and Bois, 2000). In the case of toxicokinetic data, the measured data 
generally consist of measurements from blood, breath, urine, and tissues, while the desired 
information may be values of parameters that describe the absorption, distribution, 
biotransformation, and elimination of the compounds of interest. Initial assumptions about 
the data and the parameters are tested against the available data sets. Using a sampling 
algorithm, such as the Metropolis Hastings algorithm, the proposed distributions are tested 
and thinned to yield distributions that provide the best agreement to the data. That is, the 
MCMC simulations are stochastic simulations where the selection of subsequent random 
values is influenced by the current parameter values (Bois and Maszle, 2009). The goal is 
that improved agreement between model and data will result as the simulation progresses. 
Each chain should be inspected to establish that “equilibrium” has been achieved, and 
further, multiple chains with different starting points (i.e., seed values) should be executed to 
test for consistency among chains.
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The statistical model parameters are summarized in Table 1. The parameters to be sampled 
and optimized (KTdivKI, KI, and KLN) were transformed so that they would be described 
by distributions of the means of the natural logarithm of the parameter value (M_lnParam) 
and the associated variances (V_lnParam).
MCMC analysis further requires assumptions about the data that were measured (the mass 
of coal dust in the lung [Mlun] and the mass of coal dust in the hilar lymph nodel [Mhil]) 
and that were the ultimate source of information about the distributions of parameters that 
cannot be directly measured. The variance of the measurement error for these measured 
covariates was designated Ve_Meas.
Bayes' theorem specifies that the posterior probability distribution of the model unknowns 
(ψ, in this case, toxicokinetic parameters), given experimentally measured data (y, in this 
case, amounts of coal dust in lymph nodes and lung) is proportional to the product of the 
priors for the means (μ), variance (Σ), and error (σ2); measurements, given the toxicokinetic 
parameters and error model; and the population model (the toxicokinetic parameters, given 
the prior means and variance of the toxicokinetic parameters (Bernillon and Bois, 2000). 
Mathematically, this theorem is expressed as follows (per Bernillon and Bois, 2000, Eq. 
(9)):
For the present analysis, ψ= {lnKTdivKI, lnKI, lnKLN},
μ = {M_lnKTdivKI, M_lnKI, M_lnKLN},
Σ = {V_lnKTdivKI, V_lnKI, V_lnKLN},
σ2 = {Ve_Mhil, Ve_Mlun},
and y = {Mhil, Mlun}, as defined in Table 1.
In an MCMC analysis, multiple “levels” can be considered. For each parameter, separate 
distributions of that parameter are developed at the “study” level, but in combination, these 
study-level distributions must be consistent with the distribution for the parameter as defined 
at the higher “population” level (i.e., same shape). In this case, the UK and US studies were 
each considered to be a different subpopulation. This formulation is consistent with the way 
the data were previously analyzed and is also typical in treatment of data from different 
studies, even in the absence of differences with respect to national origin. The distributions 
for M_lnParam were truncated normal distributions, while the V_lnParam values were 
assumed to follow an inverse gamma distribution. The Ve_Meas distributions were 
characterized as log uniform. The distribution shapes are consistent with those used for 
parameters for biokinetic processes in other MCMC analyses (U.S. EPA, 2009; Evans et al., 
2009; Chiu et al., 2009) and are typically used in Bayesian population modeling (Hack et al., 
2006).
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As noted above, the outputs of a Bayesian analysis are derived from the prior assumptions 
and information that is inherent in the data. Highly uninformative prior parameter 
distributions were used to avoid bias, so that the posteriors were determined by the data 
alone. Upper and lower limits for the priors were selected to encompass previously derived 
deterministic values with ample range for determination of alternative optimal values (U.S. 
EPA, 2009). The use of uninformative priors is considered a more robust, less biased 
approach to parameter estimation and strengthens the confidence that the parameter values 
represent a global optimum rather than a local optimum.
Multiple chains of MCMC optimizations (2000 iterations per chain, results reported for 
every fifth iteration) were produced by using different seed values for the MCMC algorithm. 
The outputs from the last 1000 iterations (only each 5th iteration is used, so 200 of the final 
1000 iterations are used per chain) are used to compute the parameter descriptors for each 
chain. The results of three chains are used to determine convergence. The average of these 
three values is reported in Table 1 as the posterior value. Occasionally chains produced fatal 
errors; when this happened, such events typically occurred early in the chain and the results 
were discarded. We attribute these occurrences to the selection of broad, highly 
uninformative prior parameter estimates which initially include parameter values that were 
more likely to be incompatible with successful simulation of the data than values selected 
after multiple iterations have narrowed the range of values. Preliminary analyses of the 
chains consisted of evaluating the progress of the chain by viewing the changes in the log 
likelihood function (LLF) as the iterations progressed (the objective of the optimization 
process is to maximize the LLF). This inspection ensured that the chain was sufficiently 
stable that the last 1000 iterations would yield an acceptable set of “optimal” parameter 
values from the chain. Once three or more acceptable chains had been produced, an initial 
assessment of the consistency of the results was made by comparing the average of the 
LLFs. If one chain appeared to be an outlier (with substantially lower average LLF), 
additional chains were initiated, until a third chain with a comparable average LLF was 
produced.
Initial optimizations with KT, KI, and KLN as the varied parameters were attempted, using 
MCMC simulation. The first three successful chains did not converge (per the criterion 
described below in Section 2.3.1, “Convergence of Model Parameter Estimates”). A fourth 
chain was completed, and it was noted that three of these chains produced KLN estimates 
similar to the values previously determined (Kuempel et al., 2001a,b; Tran and Buchanan, 
2000). The KI and KT values did not converge when the subset of chains with similar KLN 
values were evaluated (results not shown). It was noted, however that the difference between 
the mean values of M_lnKT and M_lnKI was consistent in multiple trials, but the individual 
values of M_lnKT and M_lnKI were different from trial to trial (note that lnKT – lnKI = 
ln(KT/KI) = constant, therefore the ratio KT/KI would be constant). The parameterization of 
the model was altered such that the parameter KT was redefined as KT = KI × KTdivKI, 
where KTdivKI is the ratio of KT to KI. This reformulated model produced convergent 
model parameter estimates, as described below in Section 3.
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2.3. Evaluation of model output
2.3.1. Convergence of model parameter estimates—The convergence (similarity) 
of results among chains was analyzed by comparing the means and variances of the 
parameter estimates through the use of the “R” statistic, where R = 1 indicates perfect 
convergence (Gelman and Rubin, 1992; Gelman, 1996; Gelman et al., 1996). Gelman et al. 
(1996) indicated that PBPK model parameter value estimates demonstrated acceptable 
convergence if √R < 1.2.
2.3.2. Visualization of output—MCSim does not provide for the automated generation 
of plots, etc. Output files were analyzed in Microsoft Excel spreadsheets. The M_lnParam 
estimates were converted back to deterministic estimates of central tendency for the 
parameter values. These values were used to generate plots wherein the model predictions 
could be compared to the calibration data.
2.3.3. Agreement between model and measured amounts of dust in the lungs 
and lung-associated lymph nodes—The mean bias and mean squared error of the 
model predictions were calculated as described in the following equations (also as reported 
earlier (Kuempel et al., 2001a,b; Tran and Buchanan, 2000)).
The fold error was calculated as the observation/prediction or prediction/observation, 
whichever was greater.
2.3.4. Sensitivity analysis—A sensitivity analysis was conducted wherein each 
parameter value was increased by 1 percent and the corresponding change in output was 
determined. Sensitivity coefficients were normalized to the output value and parameter 
value to yield a normalized sensitivity coefficient (NSC) equal to the fractional change in 
output divided by the fractional change in input. A positive value indicates that the output 
increased when the input parameter was increased while a negative value indicates that the 
output decreased when the input parameter value was increased. The scenario that was 
simulated was for a worker exposed to a constant concentration for 36 years followed by 0 
or 10 years of retirement. These values were selected as being the average years worked in 
mining and the average post-exposure duration in the US coal miner data (Kuempel et al., 
2001a). NSCs were calculated for dust accumulations in the lung and lung associated lymph 
nodes.
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All of the parameters to be optimized (Table 1) converged. The final parameter values were 
not near the upper or lower ends of the initial ranges; therefore the priors were demonstrated 
to have been sufficiently broad, so as to not bias the results. The central tendency estimates 
are similar to those of Kuempel et al. (2001a) and Tran and Buchanan (2000) (Table 2). The 
KT/KI ratio demonstrated the greatest consistency between groups (US vs. UK) and across 
the analyses (current, Kuempel et al., 2001; Tran and Buchanan, 2000). The KI values 
showed the greatest differences in central tendency values, but also the greatest variation 
within groups, suggesting that the seeming differences between groups are due to overall 
uncertainty regarding this parameter. The KLN values were intermediate in their consistency 
across groups and analyses.
Fig. 2 shows the observed and predicted values for the combined data of US and UK miners 
based on the population central tendency estimates of the parameter values (Table 2). (US 
and UK data are separately compared to both central tendency and group estimates in 
figures found in Appendix B.) Residuals were compared to observed lung and lymph node 
burdens for simulations using the group-specific values (Figs. 3 and 4). For miners with low 
lung and lymph node dust burdens, the model tended to over predict the dust burden, while 
for miners with higher observed dust burdens, the model tended to underpredict what was 
observed. This same trend was observed in earlier analyses of the US coal miner data 
(Kuempel et al., 2001a,b).
3.2. Quantitative assessment of the agreement between the modeled and predicted values
The model tended to underpredict the lung data of both the US and UK miners, as indicated 
by the bias values (Table 3). The average lung dust underprediction was less for the UK 
miners than the US miners, when population model parameter values were used, and 
roughly equal when group-specific model parameter values were used. The direction of bias 
of the lymph node dust predictions different between the simulations with population and 
group values for both US and UK miners, and the bias was generally less than for the lung. 
On average, the model predictions were within a factor of just less than 2 of the 
experimentally measured amounts of dust in lungs and lymph nodes. Almost all of the 
predictions for miners were within 10-fold of the measured values; most of the instances 
with the largest fold errors were in the UK miners. Of the 15 cases where the lung dust 
predictions for UK miners were in error by 10-fold or greater, 14 of these cases had 
measured concentrations that were higher than predicted. This suggests an underestimation 
of the total coal mine dust exposure among those miners, a greater particle deposition 
fraction, and/or reduced clearance of particles than predicted on average.
3.3. Sensitivity analysis
An analysis was conducted to evaluate the sensitivity of the lung and lymph coal dust 
estimates to the values of the model parameters. For this analysis, the deterministic model 
(i.e., a model with unique, rather than distributed, parameter values) with the mean 
population parameter values was used, and the tissue coal dust content was simulated for a 
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worker exposed to 3 mg/m3 coal dust for 36 years (average values in US coal miner group 
(Kuempel et al., 2001a), starting at age 22 (until age 58), followed by either zero or 10 years 
(to age 68 years) with no additional exposure. The predicted time course of the dust content 
of the lungs and associated lymph nodes are depicted in Fig. 5. The predicted lung and 
lymph node dust content had a linear relationship to the values of C (concentration), FD 
(fractional deposition in the alveolar region), DE (days exposed per year), and VI (volume 
inhaled per day) at both times. The sensitivity coefficients for the kinetic parameters are 
summarized in Table 4. The value of KLN has only a modest impact on the amount of coal 
dust in the lung, but is a key determinant of the predicted amount in the lymph nodes (as 
expected). By contrast, KTdivKI has almost the same impact on predictions in both tissues 
at both times. That is, a change in KTdivKI (e.g., 10 percent increase) would change the 
levels of dust in both the lung tissue and the lymph node equally (e.g., a 6% to 7% 
decrease). Thus, the optimized values of the KT/KI ratio determine the total lung plus lymph 
node burden, while the value of KLN determines the fraction of the total tissue burden 
which is located in the lymph nodes. KI had little impact on the tissue dust burdens in these 
scenarios, but the sensitivity of the model predictions to KI was observed to be greater at 
retirement than at autopsy. Thus, while limited information on KI can be derived from 
samples in which the gap between retirement is longer, when the gap is shorter, information 
on KI, independent of KT or the KT/KI ratio, can also be discerned.
The fractional deposition in the alveolar region (FD) was considered “fixed” in this analysis. 
Kuempel et al. (2001a) used an MMAD of 5.0 μm (GSD 2.1) for respirable coal mine dust 
based on studies published at that time, and the ICRP (1994), Table F.2 estimate of FD = 
0.12 for heavy work and mouth breathing. More recent characterizations of respirable coal 
dust yield smaller median particle sizes. A study in which a total of 83 underground samples 
were taken at 13 mines reported respirable particle sizes ranging from the lowest MMAD of 
0.9 μm (GSD 2.32) to the highest MMAD of 3.6 μm (GSD 1.32), with the median of the 
medians being 2.1 μm (GSD 1.65) (Page, 2003). Estimates of FD for various particle size 
distributions corresponding to ranges reported by Page (2003) and previously used by 
Kuempel et al. (2001a) were calculated using different breathing scenarios in the currently 
available version of MPPD (MPPD 2.11, 2009) (Table 5) with two combinations of 
breathing frequency and tidal volume that yield the same ventilation rate. Within this set of 
FD estimates, the values vary by almost seven fold. The choice of tidal volume had a modest 
impact (∼1.3-fold higher deposition at the higher tidal volume) for a constant particle size 
and same mode of breathing. For a given mode of breathing, variability in particle size and 
distribution could produce as much as a 2.3-fold change in the alveolar deposition estimate. 
The mode of breathing had less impact at the smaller (0.9 and 2.1 μm) particle sizes, but the 
greatest variability at the 3.6 μm particle size (as much as a 4.5-fold difference in deposition 
for oral vs. nasal breathing).
If the FD value used in the simulations is not representative of the central tendency 
experienced by the subjects (as a group), values of KT are likely to be erroneous. The 
process of tracheobronchial clearance removes mass that has not penetrated into the 
interstitium and lymph nodes. If the model value of FD is, for example, an overestimate, 
then the optimal value of KT could be altered to compensate for the larger mass of coal dust 
that must be cleared from the alveolar region (within biologically reasonable set of 
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parameter values, e.g., Table 4 in Kuempel et al. (2001a)). To the extent that any errors in 
FD are likely to be equally applicable to the two mining populations, there is not likely to be 
any alteration to the interpretation that the US and UK miners' lung and lymph node burdens 
can be described by a common set of parameters. However, values of the other parameters 
(KT and KLN) may not be “true” values for these processes if other key parameters are not 
accurately specified. For this reason, if external information is available to estimate the true 
value of any of these parameters, it provides a basis for fixing that measured value and 
estimating the other parameters. In the best-fitting model in Kuempel et al. (2001a) (using a 
systematic grid search within biologically plausible ranges of KT, KI, and KLN identified 
from human and animal studies in the literature), KT was identified as 0.001 per day, which 
is equal to the measured clearance rate coefficient in a study of workers 200 days after 
inhalation of radiolabeled tracer particles (Bailey et al., 1985). Estimation of KI was also 
estimated in the systematic search, starting with that KT value and fitting the model (by 
minimizing the mean squared error) to the measured lung and lymph node data. Similarly, 
additional information on the variability of FD or other factors affecting coal dust deposition 
(within or between groups) could allow a refined estimate of the variability of KT (or 
KTdivKI) to be derived.
4. Discussion
Data from the two previously-identified studies of US and UK coal miners (Kuempel, 2000; 
Tran and Buchanan, 2000) were used in these analyses. Initial simulations with the US data 
alone were conducted in which optimizations of KT, KI, and KLN were attempted, using 
MCMC simulation. It was determined that only the ratio of KT and KI was consistent, and 
that the parameter estimates failed to converge even when subsets of chains with similar KI 
estimates were evaluated. In subsequent simulations, the parameters were regrouped such 
that the ratio of KT to KI (KIdivKI) was to be estimated instead of KT. The reformulated 
parameterization led to a successful MCMC parameterization. The central tendency values 
were similar to those derived from the previous deterministic approaches.
The structure of this three-compartment human long-term clearance and retention model was 
developed based on biologically-relevant pathways, and the transfer rate coefficients were 
determined to be first-order (i.e., not dose-dependent) (Kuempel, 2000). This model 
structure was found to provide the best fit to several human data sets (Kuempel et al., 2001a; 
Tran and Buchanan, 2000; Gregoratto et al., 2010, 2011). Earlier simple first-order (one 
compartment) models provided poorer fit to the human lung burden data (as discussed in 
Kuempel, 2000; Kuempel et al., 2001a; Kuempel and Tran, 2002). Evaluations of possible 
dose-dependent impairment of alveolar macrophage-mediated clearance (non-first order) as 
observed in rats (i.e., “overloading”) (Morrow, 1988; Bellmann et al., 1990) was not found 
to improve the model fit of the three-compartment sequestration model (Kuempel, 2000; 
Tran and Buchanan, 2000; Kuempel and Tran, 2002). However, accounting for particle 
sequestration substantially improved the model fit to the data and the prediction of the long-
term retained lung burden of insoluble particles in humans (Kuempel et al., 2001a; Tran and 
Buchanan, 2000; Gregoratto et al., 2010).
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Mathematically, this model consists of a series of differential equations that are integrated 
over time to predict individuals' lung and lymph node particle burdens (Kuempel et al., 
2001a). Previously, Kuempel et al. (2001a) iteratively varied the clearance parameters 
(using a systematic grid search approach) to determine the best fit of the model to the data. 
Biologically plausible ranges in which to search for alternatives to the initial parameter 
values were based on data from the literature (Table 4 of Kuempel et al. (2001a)). 
Variability in the clearance rate coefficients was characterized in the US coal miner 
population using a multivariate optimization approach (Kuempel et al., 2001a). In the 
current analysis, MCMC analyses permitted simultaneous estimation of the distribution of 
parameter values.
Gregoratto et al. (2010) adapted this model (Kuempel et al., 2001a) into a simplified form 
using exponential decay functions, which is consistent with the expression of radioactivity in 
the lungs as described by ICRP (1994). The model structure was retained, although the 
model parameters were renamed; thus, KT and mT; KI and mI; and KLN and mLN (in Kuempel 
(2000) and Gregoratto et al. (2010), respectively). In addition, Gregoratto et al. (2010) 
introduced the terms AIseq and m, as follows:
AIseq is the proportion of the inhaled particle mass deposited in the alveolar region that is 
not cleared from the lungs (i.e., sequestered. The complementary fraction (1 – AIseq) clears 
with an overall rate m. Gregoratto et al. (2010) uses these terms to define an equivalent 
model of the total retention in the alveolar-interstitial region and lung-associated lymph 
nodes. Based on the best-fitting model parameters in Kuempel et al. (2001a), “default” 
values of AIseq = 0.32 and m = 0.0015/day were estimated in Gregoratto et al. (2010). 
Similar (but slightly higher) values were estimated by Gregoratto et al. (2010) as best fits to 
three additional human data sets: (1) 900-day follow-up in 10 volunteers inhaling gold-
labeled Teflon particles (Philipson et al., 1996); (2) 15-year follow-up of 7 workers who 
inhaled radioactive Co (60Co) in the same incident (Davis et al., 2007); and (3) up to 30-year 
measurements of 9 workers who received an accidental inhalation exposure to plutonium 
oxides at the US Rocky Flats Plant (ORAUT 2007). The best estimates to those three data 
sets (averaged) were: AIseq = 0.37 and m = 0.0027/day.2 In addition the rate coefficients 
were estimated as: mT = 1.7 × 10−3/day; mI = 1.0 × 10−3/day; and mLN = 3 × 10−5/day 
(Gregoratto et al., 2010, 2011).
2In a subsequent “validation” analysis fitting this model to data of two individual cases of inhalation exposure to americium 
plutonium mixtures, even higher parameter values were estimated: AIseq = 0.0.6-0.65 and m = 0.006d-1 (Gregoratto et al., 2011), 
although these estimates were close to the limits of the 68% probability range for the intersubject variability estimated in Gregoratto et 
al. (2010).
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The comparable values in the US coal miner data were: KT = 1.0 × 10−3/day; KI = 4.7 × 
10−4/day; and KLN = 1 × 10−5/day (Kuempel et al., 2001a). Thus, it can be seen that the 
clearance rate coefficients in Gregoratto et al. (2010) are approximately 2–3 times higher. 
Given that KT and KI are correlated and that the lung clearance process represented by the 
rate coefficient KT is competitive to interstitial-sequestration process represented by KI, 
higher values of KT would require higher values of KI in order to fit the lung burden data 
(thus, either set of parameters may adequately fit the coal dust data). Likewise, the model 
calibration and coal dust (non-quartz) parameter estimates in UK coal miners gave slightly 
different (but consistent) parameter estimates: KT = 1.3 × 10−3/day; KI = 3 × 10−4/day 
(fixed); and KLN = 1.6 × 10−5/day (geometric mean) (Tran and Buchanan, 2000, Table 2.7). 
The arithmetic mean estimates (KT and KLN) were up to 50% higher (Tran and Buchanan, 
2000), Table 2.7. In the current paper, the MCMC analyses show that the best-fitting 
parameter estimates in the US and UK coal miner data are consistent with a single 
distribution in a combined population.
All of these analyses have shown that accounting for sequestration of some portion of the 
inhaled dose is necessary to adequately predict the long-term lung burden of insoluble 
particles in several human data sets. This sequestration process was found to be first-order 
(i.e., not dose-dependent). Thus, even at low exposures, the current lung models based on 
simple (one compartment) first-order clearance would underpredict the human long-term 
retained lung dose – including the rat lung overload model structure at low exposure (since 
the rat lung overload model is first-order at non-overloading doses). The ICRP (1994) 
HRTM also underpredicts the long-term lung burden although not as much since it actually 
consists of three one-compartment alveolar models.
The current analysis and previous human studies provide consistent evidence in support of 
the proposed revision of the alveolar-interstitial region of the ICRP (1994) HRTM (Bailey et 
al., 2007, 2008; Gregoratto et al., 2010) to adopt the sequestration model structure 
developed in Kuempel (2000), Kuempel et al. (2001a). This model structure has been shown 
to improve the estimates of the long-term retained lung burdens of poorly-soluble particles 
in humans, including those with relatively low inhaled particle exposures (Gregoratto et al., 
2010, 2011; Avtandilashvili et al., 2012). This sequestration model also improves the 
biological basis of the particle retention description in the alveolar region, and increases the 
parsimony of the model structure and parameters. These are the reasons the original model 
structure (Kuempel, 2000; Kuempel et al., 2001a), as fit to several other human data sets, 
was proposed for the pending update of the ICRP (1994) HRTM (Bailey et al., 2007; 
Gregoratto et al., 2010). The current analysis provides further support for this pending 
update by providing estimates of the distribution of parameter values in the US and UK coal 
miner data in addition to estimates of the best-fit parameter values to the combined data 
(Kuempel, 2000; Kuempel et al., 2001a; Tran and Buchanan, 2000). The lack of a clear 
difference in quality of the model agreement to the data when optimized values for group-
specific or population values were used (e.g., Fig. B1 vs. Fig. B2, and Fig. B3 vs. Fig. B4) 
support the use of a common set of distributed model parameter estimates. These 
distribution estimates provide useful information to further characterize the variability in 
lung burden predictions in worker populations. The distributions of parameter values 
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estimated in the current analysis are consistent with those reported in other human studies 
(Gregoratto et al., 2010, 2011; Avtandilashvili et al., 2012), and as such would be expected 
to provide similar estimates of the long-term retained lung burden at similar exposure 
conditions.
Concerning particle type, the Tran and Buchanan (2000) study – which included data on 
individual coal miners' exposures and lung and lymph node burdens to respirable quartz, as 
well as to non-quartz dust) – showed differences in the estimated clearance rate coefficients 
for these two dusts. The rate of alveolar-macrophage mediated clearance (Kt) was estimated 
to be lower for quartz than for non-quartz fraction of dust in miners' lung, and the rate of 
translocation to the lymph nodes was estimated to be higher for quartz (Tran and Buchanan, 
2000). These findings are consistent with those reported by Seaton and Cherrie (1998) 
showing increased translocation of quartz to the hilar (lung-associated) lung nodes. 
Subsequent model development (e.g., HRTM) would be needed to differentiate the rate 
coefficients for high toxicity (quartz) and lower toxicity (e.g., coal) particles. Another area 
of model development that is needed is the evaluation of clearance and retention of 
nanoparticles relative to larger respirable particles (MacCalman et al., 2009).
5. Conclusions
The two data bases (US and UK miners) can be reasonably described by a common set of 
parameter values, an interstitialization rate (KI) of 0.194/year, a translocation/
insterstitialization ratio (KTdivKI) of 2.51, and a lymph node sequestration rate (KLN) of 
0.00489/year. The central tendency values of the parameters differ only modestly (75 
percent difference for KI, 23 percent for KTdivKI, and 40 percent difference for KLN) 
between the two groups. Overall, the model tends to underpredict both lung and lymph node 
dust burdens, although on average the model predicted burdens are within a factor of two of 
the measured values. Simulations of alveolar deposition of dust based on different reported 
coal particle size estimates (MMAD and GSD) for different breathing scenarios (nasal, oral, 
or oronasal) indicate the potential for variability in fractional deposition, which was a 
“fixed” parameter in the model. The extent to which the value of fractional deposition used 
in the model is not representative of what any individual miner experienced cannot be 
determined. However, because the discrepancy is likely to be similar between the groups, 
the conclusion that the general structure of the model is appropriate and central tendency 
parameter values are similar between groups remains robust.
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A.1. Base model equations and initial parameter values
State parameters
Mdep – mass of dust deposited in lung (mg)
Malv – mass of dust in alveolar portion of lung (mg)
Mint – mass of dust in interstitial portion of lung (mg)
Mhil – mass of dust in hilar lymph nodes associated with lung (mg)
Mclr – mass of dust cleared from lung gas exch region to tracheobronichal region (mg)
Additional model output
Mlun – mass of dust in alveolar and insterstitial interstitial portions of lung (mg)
Input
C – dust conc in air (mg/m3) (Described as step function with the value changing at specified set points.)
Constants
FD = 0.12 – fractional deposition particle mass in alveolar region of lungs (dimensionless)
DE = 250 – days exposed per year (days)
VI = 13.5 – volume inhaled per working day (m3/day)
Optimized parameters (initial model)
KTy –alveolar clearance rate to tracheobronchial region (per year)
KLNy – transfer rate from interstitium into lymph node (per year)


















dMdep/dt = FD × C × DE × VI mass deposition in lung (mg/year)
dMclr/dt = KTy × Malv clearance to tracheobronchial region (mg/yr)
RI = KIy × Malv first order transfer from alveolar region to interstitium (mg/yr)
dMalv/dt = dMdep/dt – dMclr/dt – RI mass balance for alveolar region (mg/yr)
dMhil/dt = KLNy×Mint accumulation in hilar lymph nodes (mg/yr)
dMint/dt = RI – dMhil/dt Mass balance for interstitium (mg/hr)
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Mlun = Malv + Mint
Revised Model Equations and Initial Parameter Values
State parameters
Mdep – mass of dust deposited in lung (mg)
Malv – mass of dust in alveolar portion of lung (mg)
Mint – mass of dust in interstitial portion of lung (mg)
Mhil – mass of dust in hilar lymph nodes associated with lung (mg)
Mclr – mass of dust cleared from lung gas exch region to tracheobronichal region (mg)
Additional model output
Mlun – mass of dust in alveolar and insterstitial interstitial portions of lung (mg)
Input
C – dust conc in air (mg/m3) (Described as step function with the value changing at specified set points.)
Constants
FD = 0.12 – fractional deposition particle mass in alveolar region of lungs (dimensionless)
DE = 250 – days exposed per year (days)
VI = 13.5 – volume inhaled per working day (m3/day)
Optimized parameters (initial model)
KTdivKI –ratio of alveolar clearance rate to tracheobronchial region to the transfer rate from alveolar tissue to 
interstitium
KLNy – transfer rate from interstitium into lymph node (per year)


















dMdep/dt = FD × C × DE × VI mass deposition in lung (mg/year)
dMclr/dt = KTdivKI × KI × Malv clearance to tracheobronchial region (mg/yr)
RI = KIy × Malv first order transfer from alveolar region to interstitium (mg/yr)
dMalv/dt = dMdep/dt – dMclr/dt – RI mass balance for alveolar region (mg/yr)
dMhil/dt = KLNy × Mint accumulation in hilar lymph nodes (mg/yr)
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dMint/dt = RI – dMhil/dt Mass balance for interstitium (mg/hr)
Output
Mlun = Malv + Mint
Appendix B
Plots of observed vs. expected values each data set using the mean values for KT and KLN 
for both the population– and group-specific estimates are provided in Figs. B1–B4).
Fig. B1. 
Observed and predicted values for US miners, using the population central-tendency 
estimates of parameter values.
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Observed and predicted values for UK miners, using the population central-tendency 
estimates of parameter values.
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Observed and predicted values for UK miners, using the population central-tendency 
estimates of parameter values.
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Observed and predicted values for UK miners, using the subpopulation-specific central-
tendency estimates of parameter values.
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Structure of the three-compartment biomathematical model for long-term clearance and 
retention of particles in the lungs of coal miners.
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Observed and predicted values for UK miners (diamond) and US miners (×), using the 
population central tendency estimates of parameter values. Diagonal line indicates perfect 
agreement.
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Residual (predicted-observed) values for US miners, using the subpopulation-specific 
central-tendency estimates of parameter values.
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Residual (predicted-observed) values for UK miners, using the subpopulation-specific 
central-tendency estimates of parameter values.
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Predicted time course of coal dust in the lung (Mlun) and lung-associated (hilar) lymph 
nodes of a miner exposed to 3 mg/m3 coal dust for 36 years, from age 22 to 58 years old, 
until death at age 68 years old.
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Table 2
Comparisons of model parameter estimates for human lung coal particle disposition.
Rate of particle 
translocation to the 
interstitial region (KI) 
(per year)
Ratio of the clearance rate 
to tracheobronchial region 
(KT) to KI (KTdivKI)
Clearance rate to the 
tracheobronchial region 
(KT) (per year)
Sequestration rate to 
lymph nodes (KLN) 
(per year)
Population value (GSD) 
(this analysis) 0.194 (1.78) 2.51 (1.59) 0.488
a 0.00489 (1.58)
US group (GSD) (this 
analysis) 0.249 (2.38) 2.24 (1.10) 0.558
a 0.00397 (1.15)
US group (Kuempel et al., 
2001a) 0.172 2.12
b 0.365 0.00365
UK group (GSD) (this 
analysis) 0.142 (2.63) 2.77 (1.08) 0.393
a 0.00557 (1.15)
UK group (GSD) (Tran and 
Buchanan, 2000) 0.172
c 2.76b 0.475 0.00584
a




Assumed equal to value of Kuempel et al. (2001a).
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Table 4
Sensitivity coefficients for predicted burden of coal dust in the lungs and lung-associated lymph nodes of 
miners.
Parameter Normalized sensitivity coefficient
Lung coal dust Lymph node coal dust
At retirement 10 years after retirement At retirement 10 years after retirement
KTdivKI −0.67 −0.69 −0.64 −0.66
KI −0.08 0.00 0.07 0.04
KLN −0.08 −0.13 1.20 1.18
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Table 5
MPPD entire lung alveolar region deposition fraction output for different breathing scenarios by particle size.
Breathing scenario
Particle size MMAD (GSD)
0.9 μm (GSD 2.32) 2.1 μm (GSD 1.65) 3.6 μlm (GSD 1.32) 5.0 μm (GSD 2.1)
Tidal volume = 1607 ml, 17.5 breaths per minute
Nasal or Oronasal (normal augmenter) 0.0899 0.0910 0.0754 0.0495
Oral 0.1452 0.2406 0.3389 0.1879
Oronasal (mouth breather) 0.1326 0.2036 0.2707 0.1551
Tidal volume = 1143 ml, 24.6 breaths per minute
Nasal or Oronasal (normal augmenter) 0.0701 0.0712 0.0612 0.0395
Oral 0.1135 0.1906 0.0612 0.0395
Oronasal (mouth breather) 0.1038 0.1614 0.2226 0.1238
Calculated using MPPD 2.11 (2009).
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